Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs

PALO ALTO, Calif., June 10, 2019 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of therapies for rare and ultra-rare diseases, today announced the appointment of... Biopharmaceuticals, Personnel Eiger BioPharmaceuticals, lonafarnib
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news